Evidence map›Paper›PMID 36325204›Full record

ArticleJournal of education and health promotion2022

The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran.

Effat Iranijam, Hassan Ghobadi, Somaieh Matin, Shahram Habibzadeh, Hamed Zandian, Jafar Mohammadshahi, Shahnaz Fooladi, Abdollah Dargahi, Elham Safarzadeh, Mohammad Negaresh and 5 more

Abstract read
In one paragraph

Article in Journal of education and health promotion, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Effat IranijamDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Hassan GhobadiDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Somaieh MatinDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Shahram HabibzadehDepartment of Infectious Disease and Tropical Medicine, Ardabil University of Medical Science, Ardabil, Iran.
Hamed ZandianSocial Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Jafar MohammadshahiDepartment of Infectious Disease and Tropical Medicine, Ardabil University of Medical Science, Ardabil, Iran.
Shahnaz FooladiDepartment of Anesthesiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Abdollah DargahiSocial Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Elham SafarzadehDepartment of Microbiology and Immunology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Mohammad NegareshDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Javad HosseiniDepartment of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Ali Hossein SamadiDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Saeed HoseininiaDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Hossein SalehzadehDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Sharareh DezhkamDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfection with COVID-19 has resulted in considerable mortality all around the world. This study aimed to investigate the effect of convalescent plasma on the treatment of hospitalized patients with COVID-19 in Imam Khomeini Hospital at Ardabil, Iran. MATERIALS AND

methodsIn this quasi-experimental clinical trial, patients over 18 years of age with polymerase chain reaction-positive COVID-19 were admitted based on the clinical criteria of respiratory distress with hypoxia (O

resultsAnalyses revealed that length of stay in hospital was significantly lower in the CPT group as compared to the control group (

conclusionsIt seems that CPT can be used as an alternative treatment at the early stages of COVID-19 to prevent the progress of the disease, reduce the need for intubation and consequently the length of stay in hospital, and finally, decrease mortality.

Indexed as

ConvalescentCOVID-19mortalitytreatment

Identifiers

PMID36325204
PMCPMC9621377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.